| RAPT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the RAPT shares outstanding history going back to 10/31/2019:
Also see: RAPT Market Cap History RAPT YTD Return |
RAPT Shares Outstanding History — RAPT Therapeutics Share Count Over Time
As of 11/3/2025 RAPT Therapeutics has 27.71 million RAPT shares outstanding. Investors often track the RAPT shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows RAPT share count trends over time, with 25 historical shares outstanding datapoints presented, dating back to 10/31/2019.
| RAPT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||
RAPT Historical Shares Outstanding: +47.65% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| RAPT Stock Price Chart |
| About RAPT Therapeutics Inc |
| RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. Co. is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology. Utilizing its drug discovery and development engine, it develops selective small molecules designed to modulate the critical immune responses underlying these diseases. Its lead inflammation drug candidate, zelnecirnon (RPT193), and its lead oncology drug candidate, tivumecirnon (FLX475), each target C-C motif chemokine receptor 4 (CCR4), a drug target that potentially has broad applicability in inflammatory diseases and oncology. We show 25 historical shares outstanding datapoints in our coverage of RAPT's shares outstanding history. Understanding the changing numbers of RAPT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RAPT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RAPT by allowing them to research RAPT shares outstanding history as well as any other stock in our coverage universe. |
| RAPT Current Stock Quote |
Quotes delayed 20 minutes  Free RAPT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| RAPT Share Performance |
| Shares Outstanding Peers |
| RAPT Therapeutics (RAPT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RARE Shares Outstanding History RARX Shares Outstanding History RBOT Shares Outstanding History RCEL Shares Outstanding History RCKT Shares Outstanding History RCUS Shares Outstanding History RDHL Shares Outstanding History RDNT Shares Outstanding History RDY Shares Outstanding History REGN Shares Outstanding History More Healthcare companies » |
RAPT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
